Isothiocyanate Surfactant for Phytophotodermatitis Toxin Binding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for phytophotodermatitis, caused by exposure to furanocoumarins and other photosensitizing compounds, provide inadequate relief and are often ineffective once symptoms manifest, as they do not address the underlying skin toxin penetration and UV sensitivity issues.

Innovation Solution

The application and removal of an isothiocyanate functional surfactant, which comprises at least one isothiocyanate functional group associated with an aliphatic or aromatic carbon atom, to affected areas to boost the immune system and elevate phase II enzymes, facilitating detoxification and inflammatory response regulation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments (soap and water washing) are applied to phytophotodermatitis, then immediate removal of skin toxins is achieved, but the treatment is ineffective once symptoms manifest because toxins have penetrated into the epidermis and dermis

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidtime window for effective treatment
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent applies isothiocyanate functional compounds topically to bind with furanocoumarin toxins before they can penetrate deeply into the skin. This preliminary binding action prevents the toxins from reaching the epidermis and dermis, extending the effective treatment window beyond the traditional immediate-wash-only approach.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The isothiocyanate functional compound acts as an intermediary substance that binds to the furanocoumarin toxins. This intermediary binding prevents direct penetration of the toxins into skin tissues, allowing for safer and more effective treatment even after symptom manifestation.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If prescription topical steroids are used to reduce reaction severity, then inflammatory response is suppressed, but the underlying toxin penetration and UV sensitivity issues remain unaddressed

Engineering Contradiction:
Improveinflammatory response severityVSAvoidcomprehensive treatment efficacy
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent extracts and binds the harmful furanocoumarin toxins from the skin surface using isothiocyanate functional compounds. By removing the underlying toxic cause rather than just suppressing the inflammatory response, the treatment addresses both the symptoms and root cause of phytophotodermatitis.

Inventive Principle:
Principle #2Taking out (Extraction)

3Object-affected harmful factors

If sterile dressings and sun protection measures are applied, then infection prevention and UV shielding are achieved, but long-term skin damage and hypersensitivity cannot be fully prevented

Engineering Contradiction:
Improveinfection risk and UV exposureVSAvoidlong-term skin health outcomes
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The isothiocyanate functional compound is applied preliminarily to bind and neutralize furanocoumarin toxins before they can cause deep tissue damage and long-term hypersensitivity. This preliminary toxin neutralization, combined with standard sun protection, provides more reliable long-term skin health outcomes.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The isothiocyanate functional surfactant method provides timely and effective relief from phytophotodermatitis symptoms by enhancing immune response and detoxification, reducing inflammation and UV sensitivity, and potentially preventing long-term skin damage.

Implementation Method 1

applying an isothiocyanate functional surfactant to an area affected by phytophotodermatitis, wherein said isothiocyanate functional surfactant comprises at least one isothiocyanate functional group

Methodology Applied
Scientific EffectIsothiocyanate functional group binding: Chemical Bonding

Data Source

PatentUS10308600B2Isothiocyanate functional surfactant and associated method of use
Publication Date: 2019.06.04 THE WILLIAM M YARBROUGH FOUND
  • US10308600B2 patent drawing
  • US10308600B2 patent drawing
  • US10308600B2 patent drawing

AI summary

A method for treating phytophotodermatitis including the steps of applying an isothiocyanate functional surfactant to an area affected by phytophotodermatitis, wherein said isothiocyanate functional surfactant comprises at least one isothiocyanate functional group associated with an aliphatic and/or aromatic carbon atom of the isothiocyanate functional surfactant.